PD‐L1 (Programmed Death‐Ligand 1) is a cell surface protein that plays a key role in the immune system's regulation of immune response and is an important factor in cancer treatment. The tumour exhibited low PD‐L1 expression (1%). The gene discussed is CD274; the disease is neoplasm.